Article
Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome: an accelerated approach toward epitope-driven vaccine development.
Human vaccines & immunotherapeutics - 1 Jan 2014
Abdel-Hady Karim M, Gutierrez Andres H, Terry Frances, Desrosiers Joe, De Groot Anne S, Azzazy Hassan M E
Abstract excerpt
With over 150 million people chronically infected worldwide and millions more infected annually, hepatitis C continues to pose a burden on the global healthcare system. The standard therapy of hepatitis C remains expensive, with severe associated side effects and inconsistent cure rates. Vaccine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
